Peter Zeihan: Europe Goes Nuclear
We’ve got two major developments in Eurasia. We’re talking about Ukraine disabling two ships in the Caspian Sea and Poland getting EU approval to build…
Thought Leader: Peter Zeihan
Gottlieb sets a new standard for FDA commissioner
By Scott Gottlieb (Original source Modern Healthcare)
“Dr. Scott Gottlieb has taken industry skeptics by surprise.
When the Trump administration tapped Gottlieb to lead the U.S. Food and Drug Administration last year, branded-drug manufacturers and their investors celebrated. Others were less exuberant.
Industry observers expected Gottlieb, who advised GlaxoSmithKline and was a board member for several other drug and device makers, to protect Big Pharma’s interests.
Yet, about a year later, the FDA commissioner has quieted many of his critics. An unprecedented level of transparency and public disclosure has garnered support from across the industry. Gottlieb has tried to curb drug prices by introducing more generics. The public health community praised his policies that look to lower salt content in food and nicotine in cigarettes, as well as crack down on opioid distributors and websites.”
Click here to see more
Relevant and recent posts
Dr. Sanjay Gupta’s Top Health Stories of 2025
From the resurgence of measles to a new way to treat pain, 2025 was a challenge for public health while still offering moments of hope. Sanjay…
Thought Leader: Sanjay Gupta
Ian Bremmer: The state of global conflict in 2025
On GZERO World, Ian Bremmer takes a hard look at the biggest global crises and conflicts that defined our world in 2025 with CNN’s Clarissa…
Thought Leader: Ian Bremmer
More with this speaker
Dr. Scott Gottlieb: What’s Next for Childhood Vaccines
Thought Leader: Scott Gottlieb
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
